With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

Analysts look at the likelihood of lawmakers making moves to rein in drug middlemen this session. Also, covid-era prescription flexibility is kept in place, pharmaceutical companies take on GLP-1 ...

Achievement of first significant research milestone triggers an option exercise payment of $10 million from AstraZeneca <li /> AstraZen ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...